Australian scientists have developed a biosensor that can rapidly detect the heart failure biomarker S100A7 in saliva, offering a simple, noninvasive way to identify the disease. The breakthrough, published in Biosensors and Bioelectronics: X, could make heart failure screening more accessible, especially in remote and under-resourced communities.
The breakdown of myelin, the insulating layer around brain cells that supports brain function, is prevalent in a range of neurodegenerative diseases, aging and because of various forms of trauma.
Scientists have found a way to pick the best pacemaker for each patient, potentially making them last years longer.
Barely an hour after being wheeled into a clinical space at Oregon Health & Science University on Aug. 27, an Arkansas woman emerged with vastly improved symptoms of the Parkinson’s disease that had plagued her for the past seven years.
Patients with weak heart function who receive stem cell therapy shortly after a heart attack are at lower risk of developing heart failure and related hospital stays compared with standard care, finds a clinical trial published by The BMJ today.
After vocal cord surgery, many patients develop stiff vocal folds that impact their ability to speak. Hydrogels can help prevent this by promoting healing, but delivering hydrogels to the vocal cords is difficult.
Now, researchers have developed a biodegradable implant that can be placed directly into the brain cavity after tumor removal
Chromosomal abnormalities—numerical and structural defects in chromosomes—are a common first step in this process, often contributing to normal cells turning cancerous.
Scientists from King’s College London have successfully applied a new technology that disarms one of the most potent weapons cancer cells use to weaken the effects of chemotherapy drugs.
A new study published in JAMA Network Open by the Harvey L. Neiman Health Policy Institute reveals poverty, environmental risks, housing issues, and physical inactivity are top-ranking community-level predictors of disparities in cancer screening, prevalence, and deaths across U.S. counties.